XML 69 R57.htm IDEA: XBRL DOCUMENT v3.24.2.u1
EQUITY AND EARNINGS PER SHARE (Tables)
 6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Preferred Shares
The table below summarizes preferred shares:
Dividends Declared per Share
Number of SharesThree Months Ended
June 30,		Six Months Ended
June 30,
SeriesJune 30, 2024December 31, 2023
Liquidation Preference(A)
Issuance Discount
Carrying Value(B)
2024202320242023
Series A, 7.50% issued July 2019(C)
6,200 6,200 $155,002 3.15 %$149,822 $0.47 $0.47 $0.94 $0.94 
Series B, 7.125% issued August 2019(C)
11,261 11,261 281,518 3.15 %272,654 0.45 0.45 0.89 0.89 
Series C, 6.375% issued February 2020(C)
15,903 15,903 397,584 3.15 %385,289 0.40 0.40 0.80 0.80 
Series D, 7.00% issued September 2021(D)
18,600 18,600 465,000 3.15 %449,489 0.44 0.44 0.88 0.88 
Total51,964 51,964 $1,299,104 $1,257,254 $1.76 $1.76 $3.51 $3.51 
(A)Each series has a liquidation preference or par value of $25.00 per share.
(B)Carrying value reflects par value less discount and issuance costs.
(C)Fixed-to-floating rate cumulative redeemable preferred.
(D)Fixed-rate reset cumulative redeemable preferred.
Schedule of Common Dividends Declared
Common dividends have been declared as follows:
Declaration DatePayment DatePer ShareTotal Amounts Distributed (millions)
Quarterly Dividend
March 17, 2023April 20230.25 120.8 
June 23, 2023July 20230.25 120.8 
September 14, 2023October 20230.25 120.8 
December 12, 2023January 20240.25 120.8 
March 20, 2024April 20240.25 120.9 
June 18, 2024July 20240.25 122.4 
Schedule of Outstanding Options
The following table summarizes outstanding options as of June 30, 2024. The last sales price on the New York Stock Exchange for Rithm Capital’s common stock in the quarter ended June 30, 2024 was $10.91 per share:
Recipient
Date of
Grant/
Exercise(A)
Number of Unexercised
Options
Options
Exercisable
as of
June 30, 2024
Weighted
Average
Exercise
Price(B)
Intrinsic Value of Exercisable Options as of
June 30, 2024
(millions)
Independent DirectorsVarious2,000 2,000 $10.70 $— 
Former Manager20171,130,916 1,130,916 12.84 — 
Former Manager20185,320,000 5,320,000 15.57 — 
Former Manager20196,351,000 6,351,000 14.95 — 
Former Manager20201,619,739 1,619,739 16.30 — 
Former Manager20217,050,335 7,050,335 9.38 10.81
Outstanding21,473,990 21,473,990 
(A)Options expire on the tenth anniversary from date of grant.
(B)The exercise prices are subject to adjustment in connection with return of capital dividends.
Schedule of Basic and Diluted Earnings Per Share Calculations
The following table summarizes the basic and diluted EPS calculations:
Three Months Ended
June 30,		Six Months Ended
June 30,
2024202320242023
Net income (loss)$238,517 $386,685 $526,004 $476,634 
Noncontrolling interests in income of consolidated subsidiaries
2,961 6,889 6,413 5,589 
Dividends on preferred stock22,395 22,395 44,790 44,790 
Net income (loss) attributable to common stockholders$213,161 $357,401 $474,801 $426,255 
Basic weighted average shares of common stock outstanding486,721,836 483,091,792 485,029,307 480,642,680 
Effect of dilutive securities:(A)(B)
Stock options1,078,804—988,302 — 
Common stock purchase warrants——— 2,223,336 
Restricted stock120,151285,169197,452 247,384 
Time-based restricted stock unit awards
1,488,716—1,152,513 — 
Performance-based restricted stock unit awards
1,295,297—950,579 — 
Time vesting Class B Profits Units(A)(B)
134,776 — 67,388 — 
Performance vesting Class B Profits Units(A)(B)
141,702 — 70,851 — 
Diluted weighted average shares of common stock outstanding490,981,282 483,376,961 488,456,392 483,113,400 
Basic earnings (loss) per share attributable to common stockholders$0.44 $0.74 $0.98 $0.89 
Diluted earnings (loss) per share attributable to common stockholders$0.43 $0.74 $0.97 $0.88 
(A)Certain stock options and common stock purchase warrants that could potentially dilute basic EPS in the future were not included in the computation of diluted EPS for the periods where they were out-of-the-money or a loss has been recorded, because they would have been anti-dilutive for the period presented. There were no anti-dilutive common stock purchase warrants for all periods presented.
(B)Awards related to stock-based compensation were included to the extent dilutive and issuable under the relevant time and/or performance measures.